Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

69 results about "Tissue digestion" patented technology

Tissue digestion is a process which can be used to dispose of human and animal remains. It involves essentially dissolving the remains, reducing them to about two percent of the original body weight, depending on the size of the original specimen. Research laboratories have been using tissue digestion since the 1990s,...

Method for extracting sub-totipotent stem cell from chorion of fetal surface of placenta

The invention relates to a method for extracting sub-totipotent stem cells from a chorion of a fetal surface of a placenta. The method comprises the steps of removing an amnion and stagnated blood from the placenta, and then repetitively washing the surface of the placenta to perform sterilization; shearing the chorion of the fetal surface in a glass utensil, removing placenta lobule tissues remained on the surface as much as possible, and shearing the chorion into small blocks; washing small tissue blocks by using a screen and a great amount of normal saline, and removing residual blood cells; performing tissue digestion: performing oscillatory digestion in a constant temperature shaker by using mixed enzymes; adding a proper amount of FBS for termination after digestion, performing filtration through a filter screen, and adding a great amount of normal saline to wash filter residues to obtain cells as many as possible; performing centrifugation, abandoning supernatant, adding saline water for washing and performing centrifugation to obtain mononuclear cells; performing magnetic bead sorting (OCT-4 positive, Nanog positive and STRO-1 negative) to obtain target cells. The invention further relates to the sub-totipotent stem cells obtained by adopting the method and pharmaceutical use thereof. The sub-totipotent stem cells have excellent characteristics.
Owner:BOYALIFE

Umbilical cord tissue digestion method

The invention discloses an umbilical cord tissue digestion method. According to the invention, wharton jelly is obtained from umbilical cord, twice digestion is carried out by using different tissue digestive enzyme, filtering is carried out, and the required mesenchymal stem cells can be obtained through filtering and centrifugation. The method employs twice digestion, during primary digestion, collagenase, hyaluronidase and DNA enzyme are subjected to complex formulation for usage, wharton jelly is digested, the digestive enzyme can effectively reduce the digestion consistency and has small damage on cells; pancreatin is employed during secondary digestion, and the cell separating can be more completed. The provided method can avoid the influence of long-term digestion of digestive enzyme such as collagenase and pancreatin on cell bodies, the acquisition rate of the obtained mesenchymal stem cells is high, and the obtained mesenchymal stem cells have high activity and differentiation potential.
Owner:青岛青春派生物科技有限公司

Separation method of human placenta mesenchymal stem cells

The invention discloses a separation method of human placenta mesenchymal stem cells. The separation method comprises the following steps that placenta specimen treatment is carried out, treated placenta tissue is obtained, tissue digestion is carried out on the placenta tissue, and cell suspension is obtained; preliminary subculture of the placenta mesenchymal stem cells is carried out; further separation and culture of the placenta mesenchymal stem cells are carried out. HyQTase and DNAse I are adopted for digestion together, the placenta mesenchymal stem cells are obtained through separation, after preliminary culture, microgravity treatment and electromagnetic field and sound wave treatment are carried out, BMP4 is used for treatment many times, upper layers are removed through a differential attachment method, a serum-free medium and antioxidant are replenished in a culture bottle for culture, and the final purity is high. The stem cell characteristics of the cells are verified through detection on hereditary stability, cell surface molecule expression conditions and cellular morphology in the continuous passage process, and materials are provided for seed cells with the placenta mesenchymal stem cells as clinical application.
Owner:大连金玛健康产业发展有限公司

Human adipose sub-totipotent stem cell isolated-culture method and stem cell bank establishing method

The invention discloses a human adipose sub-totipotent stem cell isolated-culture method and a stem cell bank establishing method. The human adipose sub-totipotent stem cell isolated-culture method includes the following steps of human adipose tissue collection, sub-totipotent stem cell separation and obtaining, sub-totipotent stem cell culture and proliferation, sub-totipotent stem cell cryopreservation, product quality control, stem cell bank establishing and stem cell revivifying and annual inspection. Mixed collagenase used by the method can effectively separate sub-totipotent stem cells from adipose tissues, is homogenous in tissue digestion, no obvious tissue residual is produced, the cell activity is good, wall adherence is quick, and the homogeneity is good. Cryopreservation liquid adopted by the method can effectively maintain the cell activity, a gradient cooling box is adopted to cryopreserve cells, the cell activity is not affected, and the human adipose sub-totipotent stem cell isolated-culture method is simple in operation, convenient and high in efficiency.
Owner:GENESIS STEMCELL REGENERATIVE MEDICINE ENG CO LTD

Method for promoting directional differentiation of umbilical cord mesenchymal stem cells into chondrogenesis

The present invention provides a method for promoting directional differentiation of umbilical cord mesenchymal stem cells into chondrogenesis. The method comprises the following steps: taking out umbilical cord tissues and conducting shredding and washing, adding tissue digestion fluid for digestion, and conducting filtering to remove supernatant after the digestion to obtain umbilical cord mesenchymal stem cells; culturing the umbilical cord mesenchymal stem cells with an umbilical cord mesenchymal stem cell selective culture medium; when the cells reach 80-90% confluence, digesting the cells with low-toxic digestion fluid, then using an umbilical cord mesenchymal stem cell cryopreservation solution for cryopreservation and placing the cells in liquid nitrogen; removing the cells from the liquid nitrogen, conducting quick thawing in a 37-DEG C water bath kettle, conducting centrifugation to remove supernatant, and adding a cell recovery solution to recover the cells; removing the recovery solution and replacing an exciting solution before induction; and when the cells grow to 80-90% confluence, digestign the cells with the low-toxic digestion solution; inoculating the cells, conducting culture overnight, removing the supernatant, adding a chondrogenesis induction culture medium, and conducting culture in a hypoxic incubator at 2% oxygen concentration. Compared with the priorart, the method can stably and effectively promote the directional differentiation of the umbilical cord mesenchymal stem cells into the chondrogenesis with shorter induction time.
Owner:GUANGDONG VITALIFE BIOTECHNOLOGY CO LTD

Method for separating scylla paramamosain tissue exosome

The invention relates to a method for separating scylla paramamosain tissue exosome. The method mainly comprises the following steps: S1) performing tissue extraction; S2) performing tissue digestion;S3) performing low-speed centrifugation; S4) performing low-speed centrifugation again; S5) performing high-speed centrifugation; S6) performing high-speed centrifugation again; S7) resuspending andprecipitating; S8) performing sucrose density gradient centrifugation; S9) carrying out ultracentrifugation; S10) carrying out ultracentrifugation again; S11) dialyzing in a dialysis bag; S12) filtering with a filter membrane; S13) carrying out ultracentrifugation; and S14) resuspending and precipitating to obtain the extracted and separated exosome product. According to the method for extractingthe scylla paramamosain tissue exosome, the differential centrifugation method, the sucrose density gradient centrifugation method and the dialysis filtration method are combined, the method is stable, effective, high in purity and easy to operate, no special equipment is needed, and the extracted exosome is high in content and purity.
Owner:SHANTOU UNIV

Mesenchymal stem cell separated from placenta blood vessel with digestive enzyme composition

The invention relates to a mesenchymal stem cell separated from the placenta blood vessel with a digestive enzyme composition, in particular to the digestive enzyme composite used for a method for separating the placenta mesenchymal stem cell from the placenta blood vessel. A buffering solution containing tissue digestive enzymes is provided with added digestive enzymes which include pancreatic enzymes, deoxyribonuclease I, collagenase II, collagenase IV and hyaluronidase. In addition, the invention further relates to the method for separating the mesenchymal stem cell from the placenta bloodvessel, and the method includes the steps that the placenta is sterilized; the placenta vessel is separated from the placenta; cutting, cleaning and bloodiness filtering removal are conducted, so thatplacenta blood vessel tissue is obtained; mixed enzyme liquor is added for digestion; digestion is stopped, and interstitial fluid is filtered and collected; cell sediments obtained through centrifuging are original placenta mesenchymal stem cells, re-suspending is conducted, sampling is conducted, and the number nucleated cells and the survival rate of the nucleated cells are calculated; the obtained cells are subjected to refrigeration preservation or continuous passage and / or identified, detected and subjected to refrigeration preservation and database creation. Through the method, the efficiency of separating the mesenchymal stem cell from the placenta blood vessel can be improved effectively.
Owner:BOYALIFE

Method for measuring digestive enzyme activity of tissues of seahorse baby with enzyme linked immunosorbent assay

The invention relates to a method for measuring the digestive enzyme activity of tissues of a seahorse baby with enzyme linked immunosorbent assay. The method comprises the following steps of: (1) putting a frozen seahorse baby into a container, adding normal saline of NAC1 with the concentration of 0.7 percent or a homogenizing medium in an ice bath, homogenizing by using a multifunctional sample homogenizer, centrifuging with a centrifuge and taking supernatant fluid for later use; (2) measuring the total protein concentration of the tissues with a part of the supernatant fluid; (3) adding a substrate starch buffer solution into a container A and a container B respectively, adding the supernatant fluid obtained in the step (1) into the container B and adding iodine reaction liquid and distilled water into the containers A and B respectively; (4) sucking the solutions in the containers A and B, dripping the solutions into two holes of an enzyme label plate, putting the enzyme label plate into an enzyme label reader and detecting the absorbency of the solutions in the two holes simultaneously; and (5) calculating the amylase activity of a sample. The method disclosed by the invention is easy to operate, has low cost and high efficiency and is environment-friendly.
Owner:EAST CHINA SEA FISHERIES RES INST CHINESE ACAD OF FISHERY SCI

Preparation method and recovery method of decidua parietalis mesenchymal stem cells

The invention discloses a preparation method and a resuscitation method of decidua parietalis mesenchymal stem cells, and the preparation method comprises the following steps that tissue blocks are digested by using a high-glucose DMEM culture medium containing 40-60% by volume of Tryple-EDTA enzyme and 8-12 mg/ml of type II collagenase as a tissue digestion solution, so that the decidua parietalis mesenchymal stem cells can climb out of tissues for adherent growth; a DMEM (dulbecco's modified eagle medium) serum-free culture medium containing a serum substitute with the volume concentration of 8-12%, L-glutamine with the volume concentration of 0.5-1 mol/ml, a basic fibroblast growth factor with the volume concentration of 18-25 ng/ml, an epidermal growth factor with the volume concentration of 16-22 ng/ml and a stem cell growth factor with the volume concentration of 6-12 ng/ml is adopted as a selective culture medium to terminate digestion, and the decidua parietalis mesenchymal stem cells are resuspended, so that the purity of the decidua parietalis mesenchymal stem cells is improved, the growth of the decidua parietalis mesenchymal stem cells is accelerated, and the in-vitro rapid amplification of the decidua parietalis mesenchymal stem cells is realized.
Owner:GUANGDONG VITALIFE BIOTECHNOLOGY CO LTD

Apparatus for determining the termination of fat digestion and fat tissue digestion apparatus

To enable to yield a group of fat-derived stem cells of constant quality regardless of the individual difference in fat tissue. It is intended to provide an apparatus for determining the termination of fat digestion (1) for use in a fat tissue digestion apparatus which digests a fat tissue by placing and stirring the fat tissue with an enzyme-containing physiological saline, lactate Ringer's solution, or buffer solution in a container, wherein the apparatus for determining the termination of fat digestion comprises: a boundary-detecting unit (8) which detects the boundary between a fat tissue layer formed in the container by being left still after stirring and a cell suspension layer located below the fat tissue layer, from outside the container; a layer thickness-measuring unit (10) which measures the thickness of the fat tissue layer based on the position of the boundary detected by the boundary-detecting unit (8); a fat volume-calculating unit (12) which calculates the volume of the fat tissue layer by multiplying the thus measured thickness of the fat tissue layer by the cross-sectional area of the container; and a termination-determining unit (13) which determines the termination of digestion based on the thus calculated volume of the fat tissue layer 120
Owner:OLYMPUS CORP

Separation and purification method of umbilical cord mesenchymal stem cells

The invention relates to a separation and purification method of umbilical cord mesenchymal stem cells and belongs to the technical field of stem cells and regenerative medicine. The method comprisesthe steps as follows: separation of umbilical cord tissue: taking the umbilical cord tissue, cleaning the umbilical cord tissue and removing blood, and shearing the tissue into tissue fragments for later use; tissue digestion: taking the tissue fragments, and adding tissue digestive juice for oscillation digestion, wherein the tissue digestive juice contains neutral protease, hyaluronidase, collagenase II and DNA enzyme; after digestion, adding a stop buffer for stop, performing filtration to obtain undigested tissue blocks and filtrate, and centrifuging the filtrate to remove supernatant to obtain cells; and cell culture: inoculating a culture flask with the tissue blocks and cells, using serum-free culture medium for culture to obtain the umbilical cord mesenchymal stem cells. The separation and purification method of umbilical cord mesenchymal stem cells overcomes the defects of an enzyme digestion method and a tissue block culture method in the prior art and can obtain enough primary cells within 3-5 days.
Owner:GUANGDONG VITALIFE BIOTECHNOLOGY CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products